William A. Gahl
8Patents
2h-index
13Co-inventors
44Inventor score
Filing activity: May 30, 2008 → May 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8410063B2 | N-acetyl mannosamine as a therapeutic agent | Human Necessities | 3 | Active |
| US9341619B2 | Hyposialylation disorders | Physics | 2 | Active |
| US8822540B2 | Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation | Human Necessities | 2 | Active |
| US9095597B2 | N-acetyl mannosamine as a therapeutic agent | Human Necessities | 1 | Active |
| US9364448B2 | Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation | Human Necessities | 0 | Active |
| US10953026B2 | N-acetyl mannosammine as a therapeutic agent | Human Necessities | 0 | Active |
| US10335426B2 | N-acetyl mannosammine as a therapeutic agent | Human Necessities | 0 | Active |
| US11155521B2 | Cannabinoid receptor mediating compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.